Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereof

Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereof

US Patent 10913766 · Granted Feb 9, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FXR small molecule agonist and preparation method therefor and use thereof2025
Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphat2021
Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphat2021
Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphat2021
Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphat2021
Structures and mechanism for the design of highly potent glucocorticoids2021
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate co2021
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate co2021
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate co2021
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate co2021
Cytarabine prodrug nucleoside cyclic phosphate compound based on liverspecific d2021
Cytarabine prodrug nucleoside cyclic phosphate compound based on liverspecific d2021